Genetic Technologies Ltd logo

Genetic Technologies Ltd Share Price (NASDAQ: GENE)

-0.76

(-100%)

Live

Last updated on

Bell Icon

The stock has been delisted from the stock exchange on 16 Oct 2024

Check the interactive Genetic Technologies Ltd Stock chart to analyse performance

Genetic Technologies Ltd Key Stats

Check Genetic Technologies Ltd key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.

Previous Close
$0.765
Open
$0.79
Market Capitalization
$3.7M
Today's Volume
$22.7K
Revenue TTM
$9.7M
EBITDA
$-10.4M
Earnings Per Share (EPS)
$-0.02
Profit Margin
-124.24%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-184.98%

Global Institutional Holdings in Genetic Technologies Ltd

  • Name

    Holdings %

  • Susquehanna International Group, LLP

    0.57%

  • Morgan Stanley - Brokerage Accounts

    0.40%

  • BNP Paribas Arbitrage, SA

    0.31%

  • TWO SIGMA SECURITIES, LLC

    0.30%

  • UBS Group AG

    0.18%

  • Rhumbline Advisers

    0.08%

Analyst Recommendation on Genetic Technologies Ltd Stock

Rating
Trend

Genetic Technologies Ltd Financials

Revenue
Profit
Cash Flow
Annually
Quarterly
FY19
FY20
FY21
FY22
FY23
FY24
FY24Y/Y Change
Revenue
$5.1M
↓ 25.93%
Net Income
$-8.0M
↑ 2.27%
Net Profit Margin
-156.78%
↓ 43.22%

About Genetic Technologies Ltd

Genetic Technologies Limited, a molecular diagnostics company, engages in the provision of predictive genetic testing and risk assessment tools to help physicians manage people's health in the America, Canada, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company operates through EasyDNA, AffinityDNA, and GeneType/Corporate segments. It offers BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer. The company also markets BREVAGenplus to healthcare professionals in breast health care and imaging centers, as well as to obstetricians/gynecologists and breast cancer risk assessment specialists, such as breast surgeons. In addition, it offers various cancer risk assessment tests under the GeneType for Colorectal Cancer and GeneType for Breast Cancer brand names; and develops other risk assessment tests across a range of diseases, which include colorectal cancer, ovarian cancer, prostate cancer, coronary artery, type 2 diabetes, pancreatic cancer, melanoma, and atrial fibrillation. Further, it offers genetic testing services, including medical, animal, forensic, and plant testing. It has research and collaboration agreements with the University of Melbourne for the development and commercialization of a novel colorectal cancer risk assessment test; Memorial Sloan Kettering Cancer Center of New York and University of Cambridge, that assess the conflict among BRCA mutation carriers considering preventive surgery; and research collaboration with Harvard University, Ohio State University, and Washington University. The company was incorporated in 1987 and is headquartered in Prahran, Australia.
Organization
Genetic Technologies Ltd
Employees
55
CEO
Mr. Kevin Camilleri
Industry
Health Technology

Key Management of Genetic Technologies Ltd

NameTitle
Mr. Kevin Camilleri
Chief Executive Officer of EasyDNA
Mr. Mark Ziirsen
CFO & Company Secretary
Mr. Paul Keith Mathieson Viney B. Bus, FCI, FCPA, FGIA
Consultant
Dr. Erika Spaeth Ph.D.
Director of Clinical & Scientific Affairs

Important FAQs about investing in GENE Stock from India :

What is Genetic Technologies Ltd share price today?

Genetic Technologies Ltd share price today is as on . Genetic Technologies Ltd share today touched a day high of {{1_rba_end}} and a low of {{1_rba_st}}.

What is the 52 week high and 52 week low for Genetic Technologies Ltd share?

Genetic Technologies Ltd share touched a 52 week high of {{rba_end}} and a 52 week low of {{rba_st}}. Genetic Technologies Ltd stock price today i.e. is trending at , lower by 100% versus the 52 week high.

How to invest in Genetic Technologies Ltd Stock (GENE) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Genetic Technologies Ltd on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Genetic Technologies Ltd Shares .

What is the minimum amount required to buy Genetic Technologies Ltd Stock (GENE) from India?

Indian investors can start investing in Genetic Technologies Ltd (GENE) shares with as little as ₹88.116 or $1 (as of September 04, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹881.16 in Genetic Technologies Ltd stock (as per the Rupee-Dollar exchange rate as on September 04, 2025). Learn more about fractional shares .

What are the returns that Genetic Technologies Ltd has given to Indian investors in the last 5 years?

Genetic Technologies Ltd stock has given 0.0% share price returns and 20.07% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?